Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChemring Regulatory News (CHG)

Share Price Information for Chemring (CHG)

Share Price is delayed by 15 minutes
Get Live Data
507.00    7.00 (1.40%)
Bid:
507.50
Ask:
508.50
Spread: 1.00 (0.197%)
Market Cap: £1.37b
CHG Live PriceLast checked at - London Stock Exchange

Intraday Chemring Share Chart

Offer Talks Terminated

7 Nov 2012 16:14

RNS Number : 5896Q
Chemring Group PLC
07 November 2012
 





FOR IMMEDIATE RELEASE 7 November 2012

 

 

CHEMRING GROUP PLC

Response to statement by The Carlyle Group

Chemring Group PLC ("Chemring" or "the Company") notes today's announcement by The Carlyle Group ("Carlyle") that it does not intend to make an offer for the Company.

On 17 August 2012 Chemring announced that it had received a highly preliminary expression of interest from The Carlyle Group ("Carlyle") in relation to a possible offer for the Company. In accordance with Rule 2.6(a) of the Code, Carlyle was required, by not later than 5.00 p.m. on 14 September 2012, to announce a firm intention to make an offer for Chemring in accordance with Rule 2.7 of the Code or announce that it did not intend to make an offer. At the request of the Company, the Panel consented to an extension of this deadline on 14 September and again on 12 October, to enable the parties to continue their on-going discussions regarding a possible offer for the Company.

The Company will give a further update on 27 November in respect of its preliminary results for the year ended 31 October 2012, which are expected to be announced on 24 January 2013.

Whilst Chemring continues to face near term challenges resulting from defence budget constraints in its NATO markets, which are not expected to ease in the immediate future, the Company has market leading positions and manufacturing expertise in the fields of counter-IED, countermeasures, munitions and pyrotechnics. In addition, the Company's non-NATO markets will continue to provide the business with further opportunities and gives a balanced exposure to global defence spending.

Following the announcement on 23 October, Mark Papworth has now joined the Company as Chief Executive Officer. Prior to joining Chemring, Mark served as CEO of the Gas Turbines Services division of Wood Group plc, a leading FTSE100 company. During Mark's tenure at Wood Group, he implemented and delivered a strategic review which resulted in a successful turnaround, improved manufacturing capabilities and substantial improvements in profitability.

-ENDS-

Chemring Group

Rupert Pittman Director of Communications and Investor Relations

01489 881 880 / rupertp@chemring.co.uk

 

MHP Communications

Andrew Jaques / James White

0203 128 8100

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
OTTBRBFTMBBMBBT
Date   Source Headline
3rd Jun 20264:00 pmRNSHolding(s) in Company
2nd Jun 20267:02 amRNSDirectorate change
2nd Jun 20267:00 amRNSInterim results
1st Jun 20267:00 amRNSTotal Voting Rights
28th May 20262:36 pmRNSHolding(s) in Company
22nd May 20269:15 amRNSHolding(s) in Company
21st May 20267:00 amRNSHolding(s) in Company
14th May 20267:00 amRNSHolding(s) in Company
1st May 20267:00 amRNSHolding(s) in Company
1st May 20267:00 amRNSTotal Voting Rights
1st Apr 20267:00 amRNSTotal Voting Rights
31st Mar 20263:46 pmRNSDirector/PDMR Shareholding
19th Mar 202611:00 amRNSHolding(s) in Company
4th Mar 20267:00 amRNSAppointment of non-executive director
2nd Mar 20269:15 amRNSTotal Voting Rights
20th Feb 20262:48 pmRNSResult of AGM
20th Feb 20267:00 amRNSAGM Update
16th Feb 20267:00 amRNSHolding(s) in Company
9th Feb 20267:00 amRNSHolding(s) in Company
2nd Feb 20267:00 amRNSTotal Voting Rights
23rd Jan 20264:41 pmRNSDirector/PDMR Shareholding
12th Jan 20261:35 pmRNSNotice of AGM
2nd Jan 202610:29 amRNSTotal Voting Rights
19th Dec 202511:53 amRNSHolding(s) in Company
19th Dec 202511:53 amRNSHolding(s) in Company
18th Dec 20257:00 amRNSBlock listing Interim Review
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
16th Dec 20257:00 amRNSDirector/PDMR Shareholding
15th Dec 20258:42 amRNSTransaction in Own Shares
12th Dec 20257:00 amRNSTransaction in Own Shares
11th Dec 20253:01 pmRNSAdditional Listing - Replacement
11th Dec 20257:00 amRNSTransaction in Own Shares
10th Dec 202512:41 pmRNSDirector/PDMR Shareholding
10th Dec 202512:40 pmRNSDirector/PDMR Shareholding
10th Dec 202512:40 pmRNSDirector/PDMR Shareholding
10th Dec 202512:38 pmRNSDirector/PDMR Shareholding
10th Dec 202512:36 pmRNSDirector/PDMR Shareholding
10th Dec 202512:36 pmRNSDirector/PDMR Shareholding
10th Dec 20257:00 amRNSAdditional Listing
10th Dec 20257:00 amRNSTransaction in Own Shares
9th Dec 20254:23 pmRNSDirector/PDMR Shareholding
9th Dec 20257:00 amRNSResults for the year ended 31 October 2025
9th Dec 20257:00 amRNSTransaction in Own Shares
8th Dec 20257:00 amRNSTransaction in Own Shares
5th Dec 20257:00 amRNSTransaction in Own Shares
4th Dec 20257:00 amRNSTransaction in Own Shares
3rd Dec 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.